Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00006113 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Lack of efficacy

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: MART-1 antigen
BIOLOGICAL: aldesleukin
BIOLOGICAL: gp100 antigen
BIOLOGICAL: recombinant CD40-ligand
BIOLOGICAL: recombinant interferon gamma
BIOLOGICAL: recombinant interleukin-4
BIOLOGICAL: sargramostim
BIOLOGICAL: therapeutic autologous dendritic cells
BIOLOGICAL: therapeutic tumor infiltrating lymphocytes
BIOLOGICAL: tyrosinase peptide
RADIATION: Candida albicans skin test reagent

Sponsor

University of Southern California

Collaborators

[object Object]